Article
CNBC
(2020)
The trials, called ACTIV-2 and ACTIV-3, will look at U.S. drugmaker Eli Lilly's experimental treatment known as LY-CoV555, which is being developed in partnership with Canadian biotech company AbCellera.
FoundryBase
updated about 13 hours ago
Comments
Related Chunks
Related chunks with this resource
Antibody injections, treatment - a leading candidate for COVID19 Coronavirus cure
RELATED RESOURCES
with chunks in common
2020
First human trial begins for potential antibody treatment for COVID-19 — CNN
Saved by: FoundryBase
used in 2 chunks
2020
Eli Lilly reports a reduced rate of hospitalization for coronavirus patients using its antibody treatment
Saved by: FoundryBase
used in 1 chunk
2020
U.S. pauses Eli Lilly's trial of a coronavirus antibody treatment over safety concerns
Saved by: FoundryBase
used in 1 chunk
2020
Nature: The race to make COVID antibody therapies cheaper and more potent (Oct. 2020)
Saved by: FoundryBase
used in 2 chunks
2020
As monoclonal antibody Covid-19 treatment arrives, hospitals scramble to solve logistical and ethical challenges
Saved by: FoundryBase
used in 2 chunks
MORE RELATED CONTENT
with shared categories
2023
TED: How we're using AI to discover new antibiotics | Jim Collins
Saved by: FoundryBase
used in 1 chunk
2021
New approach provides potential vaccine and treatment for Alzheimer's
Saved by: FoundryBase
used in 1 chunk
2021
HPV vaccine reduced cervical cancer rates by 87% in women, study finds - CNN
Saved by: FoundryBase
used in 2 chunks
2021
It took a pandemic, but the US finally has (some) centralized medical data | MIT Technology Review
Saved by: FoundryBase
used in 2 chunks
2021
FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline
Saved by: FoundryBase
used in 1 chunk
2021
Pfizer is testing a pill that, if successful, could become first-ever home cure for COVID-19
Saved by: FoundryBase
used in 2 chunks
2021
Scientists Are Working on mRNA Vaccines for HIV, Flu, Cancer and More - POZ
Saved by: FoundryBase
used in 3 chunks
2021
First vaccine to fully immunize against malaria builds on pandemic-driven RNA tech - The Academic Times
Saved by: FoundryBase
used in 2 chunks
2021
The same covid-19 mutations are appearing in different places | Graphic detail | The Economist
Saved by: FoundryBase
used in 1 chunk
2021
The Second Coming of RNA Medicines - Andreessen Horowitz
Saved by: FoundryBase
used in 4 chunks
No comments yet. Be the first to comment!